FSSAI suspends Dior Pharmaceuticals licence; bars products from Vatave and Neuherbs
FSSAI issued prohibition orders over manufacturing non-compliance, misleading claims and labelling issues. Dior Pharmaceuticals must halt nutraceutical operations, while Vatave Health Care and Global Healthfit Retail India have been directed to stop specified products.
FSSAI suspended Dior Pharmaceuticals’ licence over critical manufacturing non-compliance and ordered it to halt nutraceutical operations. It also barred Vatave Health Care’s Folineuro Syrup and directed Global Healthfit Retail India to stop selling Neuherbs True Vitamin over misleading claims and labelling.
Why this matters
The action continues Dior Pharmaceuticals' recent FSSAI enforcement pattern, following signals on its suspended nutraceutical manufacturing licence and Punjab plant violations.
Retail-company signals are accelerating, up 253040% QoQ.
Also reported by
- BL · Consumer & Economy — Same time